06/04/2026
A new cure for autoimmune disease â and it's a vaccine. But not the kind you're thinking of.
I'm Dr. Girnita, founder of Rheumatologist OnCall. With my colleagues Dr. Devalla and Dr. Titianu, our team treats lupus, RA, scleroderma, myositis, and multiple sclerosis across 21 US states.
I know what you're thinking. Another vaccine? Stay with me.
For the last 100 years, every vaccine we've ever made has done the same thing â train your immune system to ATTACK a virus, a bacteria, a cancer cell.
But what if your immune system is already attacking too much? That's exactly what happens in lupus, rheumatoid arthritis, multiple sclerosis, type 1 diabetes, celiac disease.
So scientists asked a brilliant question: What if we made a vaccine that does the OPPOSITE â one that teaches the immune system to STOP attacking your own body?
They invented one. They're called inverse vaccines. And they're already in human trials.
Here's what we know so far:
ð§ Multiple sclerosis: Phase 1/2 trials showed the inverse vaccine was safe and well-tolerated. The 0.5 mg dose REDUCED inflammatory brain lesions on MRI. Honestly â it didn't significantly reduce clinical relapses or slow disability yet. So it's not the finish line. But it IS proof the concept works.
ðū Celiac disease: TAK-101 (a PLGA nanoparticle inverse vaccine) reduced gliadin-specific immune attack by 88% in a placebo-controlled trial. Other platforms (TPM502, KAN-101) are also in trials.
ð Type 1 diabetes: Patients developed real immune tolerance to insulin after a single dose.
ðĶī Rheumatoid arthritis: Preclinical (animal) studies are reversing joint inflammation. Human trials being designed.
This isn't immune suppression. This isn't a biologic. This isn't a steroid.
This is a vaccine that doesn't vaccinate. It re-educates. It resets your immune system.
So tell me â why is no one talking about this?
ð Read the science:
ðŽ Tremain AC et al. "Synthetically glycosylated antigens for the antigen-specific suppression of established immune responses." Nature Biomedical Engineering. 2023.
â https://www.nature.com/articles/s41551-023-01086-2
ðū Kelly CP et al; TAK-101 Study Group. "TAK-101 Nanoparticles Induce Gluten-Specific Tolerance in Celiac Disease." Gastroenterology. 2021;161(1):66-80.
â https://pubmed.ncbi.nlm.nih.gov/33722583/
â ïļ Important: No inverse vaccine is FDA-approved yet. These are in clinical trials.
ð See our team from your couch. Telehealth rheumatology in 21 US states.
ð rheumatologistoncall.com
âïļ 650-525-4404